Connect with us

Healthcare Buzz

Tentative USFDA nod for Zydus’ Tofacitinib tablets

Zydus Cadila has received tentative approval from the US health regulator to market Tofacitinib tablets, used for the treatment of rheumatoid arthritis. Tofacitinib is used alone or with other medications to treat moderate to severe forms of rheumatoid arthritis. It helps to decrease pain, tenderness and swelling in the joints. It will be manufactured at the group’s formulations manufacturing facility at Moraiya, Ahmedabad.

Copyright © 2024 Medical Buyer

error: Content is protected !!